A proposal for a rational transfusion strategy in patients of European and North African descent with weak D type 4.0 and 4.1 phenotypes.
作者信息
Flegel Willy A, Peyrard Thierry, Chiaroni Jacques, Tournamille Christophe, Jamet Déborah, Pirenne France
机构信息
Department of Transfusion Medicine, NIH Clinical Center, National Institutes of Health, Bethesda, MD, United States of America.
Department of Pathology and Laboratory Medicine, MedStar Georgetown University Hospital, Washington DC, United States of America.
出版信息
Blood Transfus. 2019 Mar;17(2):89-90. doi: 10.2450/2018.0059-18. Epub 2018 May 3.
Abstract
摘要
相似文献
1
A proposal for a rational transfusion strategy in patients of European and North African descent with weak D type 4.0 and 4.1 phenotypes.
Blood Transfus. 2019 Mar;17(2):89-90. doi: 10.2450/2018.0059-18. Epub 2018 May 3.
2
Transfusion strategy for weak D Type 4.0 based on RHD alleles and RH haplotypes in Tunisia.
Transfusion. 2018 Feb;58(2):306-312. doi: 10.1111/trf.14411. Epub 2017 Nov 29.
3
Molecular background of D-negative phenotype in the Tunisian population.
Transfus Med. 2012 Jun;22(3):192-8. doi: 10.1111/j.1365-3148.2012.01142.x. Epub 2012 Mar 16.
4
Genetic diversity of North African populations in the 17q21 genomic region.
Mamm Genome. 2024 Sep;35(3):445-460. doi: 10.1007/s00335-024-10051-6. Epub 2024 Jul 4.
5
Genetic diversity in Tunisia: a study based on the GM polymorphism of human immunoglobulins.
Hum Biol. 2004 Aug;76(4):559-67. doi: 10.1353/hub.2004.0054.
6
Comprehensive analysis of RHD alleles in Argentineans with variant D phenotypes.
Transfusion. 2012 Feb;52(2):389-96. doi: 10.1111/j.1537-2995.2011.03297.x. Epub 2011 Aug 24.
7
High frequency of variant RHD genotypes among donors and patients of mixed origin with serologic weak-D phenotype.
J Clin Lab Anal. 2018 Nov;32(9):e22596. doi: 10.1002/jcla.22596. Epub 2018 Jun 26.
8
North African Jewish and non-Jewish populations form distinctive, orthogonal clusters.
Proc Natl Acad Sci U S A. 2012 Aug 21;109(34):13865-70. doi: 10.1073/pnas.1204840109. Epub 2012 Aug 6.
9
The DAU allele cluster of the RHD gene.
Blood. 2002 Jul 1;100(1):306-11. doi: 10.1182/blood-2002-01-0320.
10
Weak D Type 4.2.2 (DAR1.2) in an African child: Serology and molecular characterization.
Transfus Apher Sci. 2015 Apr;52(2):217-9. doi: 10.1016/j.transci.2014.12.020. Epub 2014 Dec 19.
引用本文的文献
1
Guide to Rho(D) Immune Globulin in Women With Molecularly Defined Asian-type DEL (c.1227G>A).
Ann Lab Med. 2024 Jul 1;44(4):307-313. doi: 10.3343/alm.2023.0356. Epub 2024 Feb 22.
2
First investigation of RH gene polymorphism in patients with sickle cell disease and associated blood donors in Cameroon, Central Africa.
Blood Transfus. 2024 Sep;22(5):377-386. doi: 10.2450/BloodTransfus.660. Epub 2024 Jan 29.
3
What constitutes the most cautious approach for a pregnant person with weak D type 4.0?
CMAJ. 2021 Jun 14;193(24):E916. doi: 10.1503/cmaj.78986.
4
Proceed with care: the "uncommon" serologic weak D phenotypes.
Blood Transfus. 2021 Jul;19(4):272-276. doi: 10.2450/2021.0147-21.
5
Transfusion support during childbirth for a woman with anti-U and the allele.
Immunohematology. 2021 Mar;37(1):1-4. doi: 10.21307/immunohematology-2021-001.
6
It's time to phase out "serologic weak D phenotype" and resolve D types with RHD genotyping including weak D type 4.
Transfusion. 2020 Apr;60(4):855-859. doi: 10.1111/trf.15741. Epub 2020 Mar 12.
7
Comprehensive phenotypic and molecular investigation of RhD and RhCE variants in Moroccan blood donors.
Blood Transfus. 2019 Mar;17(2):151-156. doi: 10.2450/2018.0153-18. Epub 2018 Oct 24.
8
Genotyping in Sickle Cell Disease Patients: The French Strategy.
Transfus Med Hemother. 2018 Jul;45(4):264-270. doi: 10.1159/000490858. Epub 2018 Jul 6.
9
Experience with RHD*weak D type 4.0 in the USA.
Blood Transfus. 2019 Mar;17(2):91-93. doi: 10.2450/2018.0114-18. Epub 2018 Jul 6.
本文引用的文献
1
Transfusion strategy for weak D Type 4.0 based on RHD alleles and RH haplotypes in Tunisia.
Transfusion. 2018 Feb;58(2):306-312. doi: 10.1111/trf.14411. Epub 2017 Nov 29.
2
Weak D type 1, 2 and 3 subtype alleles are rare in the Western French population.
Transfus Med. 2019 Jun;29(3):209-210. doi: 10.1111/tme.12485. Epub 2017 Nov 22.
3
Practice Bulletin No. 181: Prevention of Rh D Alloimmunization.
Obstet Gynecol. 2017 Aug;130(2):e57-e70. doi: 10.1097/AOG.0000000000002232.
4
Serologic and molecular characterization of weak D type 29.
Transfusion. 2017 Oct;57(10):2542-2544. doi: 10.1111/trf.14218. Epub 2017 Jul 3.
5
Serological weak D phenotypes: a review and guidance for interpreting the RhD blood type using the RHD genotype.
Br J Haematol. 2017 Oct;179(1):10-19. doi: 10.1111/bjh.14757. Epub 2017 May 16.
6
Strategies to identify candidates for D variant genotyping.
Blood Transfus. 2018 May;16(3):293-301. doi: 10.2450/2017.0274-16. Epub 2017 Apr 5.
7
A model for integrating molecular-based testing in transfusion services.
Blood Transfus. 2016 Nov;14(6):566-572. doi: 10.2450/2015.0070-15. Epub 2015 Sep 3.
8
It's time to phase in RHD genotyping for patients with a serologic weak D phenotype. College of American Pathologists Transfusion Medicine Resource Committee Work Group.
Transfusion. 2015 Mar;55(3):680-9. doi: 10.1111/trf.12941. Epub 2014 Dec 1.
9
Weak D in the Tunisian population.
Blood Transfus. 2015 Apr;13(2):295-301. doi: 10.2450/2014.0073-14. Epub 2014 Oct 23.
10
Paternal RHD zygosity determination in Tunisians: evaluation of three molecular tests.
Blood Transfus. 2015 Jan;13(1):59-65. doi: 10.2450/2014.0308-13. Epub 2014 Jun 19.
Zotero 插件